PCNAorg
06/13/2025
Transforming the future of pancreatic cancer demands bold innovation, and that is precisely what Pancreatic Cancer North America is doing.
NeoPancONE, a breakthrough study funded by our Canadian donors was highlighted at this year’s American Society of Clinical Oncology (ASCO) Conference. Read the latest results on our website: https://pancreaticcancerna.org/research-update-neopancone-asco/
Research Update – NeoPancONE Study Results Presented at ASCO 2025 - Pancreatic Cancer North America Groundbreaking progress against pancreatic cancer took center stage at this year’s American Society of Clinical Oncology (ASCO) conference. Among the most anticipated presentations were new results from the NeoPancONE study, an innovative clinical trial funded by our Canadian donors.
is a time to celebrate the strong, inspiring, and empowering women in our lives. The ones who uplift us, break barriers, and push for change. But there’s a silent threat rising among women that we can’t ignore.
Research shows that pancreatic cancer is on the rise in women under 55, yet it remains the deadliest major cancer. With a survival rate of just 13%, the statistics are sobering. Women deserve better - better research, better treatments, and better chances at survival. The time to act is now. Give today and demand alongside us: https://pancreaticcancerna.org/?form=donatenow
Click here to claim your Sponsored Listing.
Category
Contact the organization
Telephone
Address
800 Third Avenue FRNT A #1523
New York, NY
10022
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |
